Literature DB >> 9061180

Erosion of composite polymer matrices.

A Göpferich1.   

Abstract

The erosion of composite polymer matrices made of slow and fast eroding polymers was investigated. These matrices can be used as implants that release drugs in a preprogrammed way. To understand the mechanism of drug release, the erosion of cylindrical polymer matrices made of several layers of different polymers was investigated. A layer of poly(D,L-lactic acid) was used to separate a core and a mantle consisting of poly(1,3-bis[p-carboxyphenoxy]propane-co-sebacic acid) 20:80. The investigation of the erosion mechanism revealed that erosion is a two-phase process. Wide angle X-ray diffraction and differential scanning calorimetry proved that the crystalline polymer parts of the polyanhydride layers above and below the polylactide erode one after the other. Concomitantly, sebacic acid accumulates periodically inside the matrix and leaves it in two phases. This agrees well with the release of brilliant blue and carboxyfluorescein, two model compounds, from such implants when incorporated into the polyanhydride layers. It can be concluded that the core of the composite implant erodes with a delay of 10-14 days because the polylactide protects it against premature erosion. Theoretical erosion models that were developed to simulate erosion support the proposed mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061180     DOI: 10.1016/s0142-9612(96)00151-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

1.  A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations.

Authors:  Juergen Siepmann; Nathalie Faisant; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

2.  3D Multi-agent models for protein release from PLGA spherical particles with complex inner morphologies.

Authors:  Ana Barat; Heather J Ruskin; Martin Crane
Journal:  Theory Biosci       Date:  2008-04-26       Impact factor: 1.919

3.  A voxel-based Monte Carlo model of drug release from bulk eroding nanoparticles.

Authors:  David A Eavarone; Venkataramanan Soundararajan; Toomas Haller; Ram Sasisekharan
Journal:  J Nanosci Nanotechnol       Date:  2010-09

4.  Preparation and characterization of protein-loaded polyanhydride microspheres.

Authors:  Lin Sun; Shaobing Zhou; Weijia Wang; Qiuxiang Su; Xiaohong Li; Jie Weng
Journal:  J Mater Sci Mater Med       Date:  2009-05-08       Impact factor: 3.896

Review 5.  Biodegradable intraocular therapies for retinal disorders: progress to date.

Authors:  Noriyuki Kuno; Shinobu Fujii
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

6.  A strut graft substitute consisting of a metal core and a polymer surface.

Authors:  Ana L C Lagoa; Christian Wedemeyer; Marius von Knoch; Franz Löer; Matthias Epple
Journal:  J Mater Sci Mater Med       Date:  2007-07-03       Impact factor: 3.896

7.  Novel bioerodable eluting-spacers for radiotherapy applications with in situ dose painting.

Authors:  Francis Boateng; Wilfred Ngwa
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

Review 8.  Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.

Authors:  Nattawut Leelakanok; Sean Geary; Aliasger Salem
Journal:  J Pharm Sci       Date:  2017-10-16       Impact factor: 3.784

Review 9.  Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy.

Authors:  Lawrence Kleinberg
Journal:  Patient Prefer Adherence       Date:  2016-11-24       Impact factor: 2.711

10.  Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.

Authors:  Lawrence Kleinberg
Journal:  Core Evid       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.